| __timestamp | Bio-Techne Corporation | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 382096000000 |
| Thursday, January 1, 2015 | 40853000 | 345927000000 |
| Friday, January 1, 2016 | 45187000 | 312303000000 |
| Sunday, January 1, 2017 | 53514000 | 325441000000 |
| Monday, January 1, 2018 | 55329000 | 368298000000 |
| Tuesday, January 1, 2019 | 62413000 | 492381000000 |
| Wednesday, January 1, 2020 | 65192000 | 455833000000 |
| Friday, January 1, 2021 | 70603000 | 526087000000 |
| Saturday, January 1, 2022 | 87140000 | 633325000000 |
| Sunday, January 1, 2023 | 92493000 | 729924000000 |
| Monday, January 1, 2024 | 96664000 | 729924000000 |
In pursuit of knowledge
In the ever-evolving world of pharmaceuticals and biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Takeda Pharmaceutical Company Limited and Bio-Techne Corporation have been at the forefront of this race.
From 2014 to 2023, Takeda's R&D expenses have surged by approximately 91%, reflecting its commitment to pioneering new treatments. In contrast, Bio-Techne's R&D spending has increased by about 213%, showcasing its aggressive push into new biotechnological frontiers.
By 2023, Takeda's R&D expenditure reached a staggering 730 billion, dwarfing Bio-Techne's 92 million. This disparity highlights the scale at which these companies operate, with Takeda's spending being nearly 8,000 times that of Bio-Techne. As we look to the future, these investments will likely shape the next wave of medical breakthroughs.
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Takeda Pharmaceutical Company Limited and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Bio-Techne Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Axsome Therapeutics, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Geron Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Mesoblast Limited Allocate Funds
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Analyzing R&D Budgets: Bio-Techne Corporation vs Geron Corporation
Comparing Innovation Spending: Bio-Techne Corporation and Galapagos NV
Analyzing R&D Budgets: Bio-Techne Corporation vs Taro Pharmaceutical Industries Ltd.